Journal News

New chemical strategy boosts accuracy in proteomics

Vanshika Patel
Nov. 6, 2025

Overlabeling of peptides in proteomics mass spectrometry reduces protein identification and quantitation precision. In proteomics sample preparation, a chemical called N-hydroxysuccinimide, or NHS, is commonly used in tagging proteins to identify proteins for quantitation. However, NHS can also react with other amino acid residues, forming unwanted O-ester derivatives, which bond to oxygen atoms of amino acids such as serine, tyrosine and threonine, complicating analysis. While existing methods, such as hydroxylamine treatment, have been used to reduce excess NHS esters, it is not fully effective, and scientists lack methods to sufficiently remove overlabeled peptides.

Yana Demyanenko and a team of researchers based in the U.K. and Germany published an article in Molecular & Cellular Proteomics, where they developed a methylamine-based method to remove these O-ester modifications. They found that methylamine was the most effective in reducing overlabeled peptides among various tested reagents, such as hydroxylamine, O-methoxylamine HCl, hydrazine hydrate, Tris and ammonium hydroxide. In contrast, standard labeling without quenching led to over 25% overlabeled peptides, while hydroxylamine treatment reduced this to only 10%. Methylamine, however, reduced the overlabeling to less than 1% without affecting the labeling rate or causing additional modifications. Future research will apply this methylamine-based approach to different proteomics workflows to improve peptide identification and quantitation.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Vanshika Patel

Vanshika Patel is a Ph.D. candidate in the pharmaceutical sciences department at the University of Maryland, Baltimore. She studies vitamin A signaling and the ERK 1/2 pathway in asthma in the Kane lab. She is an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

The data that did not fit
Research Spotlight

The data that did not fit

March 5, 2026

Brent Stockwell’s perseverance and work on the small molecule erastin led to the identification of ferroptosis, a regulated form of cell death with implications for cancer, neurodegeneration and infection.

Building a career in nutrition across continents
Profile

Building a career in nutrition across continents

March 3, 2026

Driven by past women in science, Kazi Sarjana Safain left Bangladesh and pursued a scientific career in the U.S.

Avoiding common figure errors in manuscript submissions
How-to

Avoiding common figure errors in manuscript submissions

Feb. 27, 2026

The three figure issues most often flagged during JBC’s data integrity review are background signal errors, image reuse and undeclared splicing errors. Learn how to avoid these and prevent mistakes that could impede publication.

Ragweed compound thwarts aggressive bladder and breast cancers
Journal News

Ragweed compound thwarts aggressive bladder and breast cancers

Feb. 26, 2026

Scientists from the University of Michigan reveal the mechanism of action of ambrosin, a compound from ragweed, selectively attacks advanced bladder and breast cancer cells in cell-based models, highlighting its potential to treat advanced tumors.

Lipid-lowering therapies could help treat IBD
Journal News

Lipid-lowering therapies could help treat IBD

Feb. 25, 2026

Genetic evidence shows that drugs that reduce cholesterol or triglyceride levels can either raise or lower inflammatory bowel disease risk by altering gut microbes and immune signaling.

Key regulator of cholesterol protects against Alzheimer’s disease
Journal News

Key regulator of cholesterol protects against Alzheimer’s disease

Feb. 24, 2026

A new study identifies oxysterol-binding protein-related protein 6 as a central controller of brain cholesterol balance, with protective effects against Alzheimer’s-related neurodegeneration.